Literature DB >> 14744754

Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo.

Kip A West1, Ilona R Linnoila, Steven A Belinsky, Curtis C Harris, Phillip A Dennis.   

Abstract

The role of the phosphatidylinositol 3'-kinase (PI3K)/Akt pathway during tobacco carcinogen-induced transformation is unknown. To address this question, we evaluated this pathway in isogenic immortalized or tumorigenic human bronchial epithelial cells in vitro, as well as in progressive murine lung lesions induced by a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Compared with immortalized cells, tumorigenic cells had greater activation of the PI3K/Akt pathway, enhanced survival, and increased apoptosis in response to inhibition of the pathway. In vivo, increased activation of Akt and mammalian target of rapamycin was observed with increased phenotypic progression. Collectively, these results support the hypothesis that maintenance of Akt activity is necessary for survival of preneoplastic as well as transformed lung epithelial cells and suggest that inhibition of the PI3K/Akt pathway might be a useful approach to arrest lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744754     DOI: 10.1158/0008-5472.can-03-3241

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

Authors:  Filip Janku; David J Stewart; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

2.  The role of the Akt/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis.

Authors:  Regan M Memmott; Phillip A Dennis
Journal:  Clin Cancer Res       Date:  2009-12-22       Impact factor: 12.531

Review 3.  Current concepts on the molecular pathology of non-small cell lung carcinoma.

Authors:  Junya Fujimoto; Ignacio I Wistuba
Journal:  Semin Diagn Pathol       Date:  2014-06-12       Impact factor: 3.464

Review 4.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

Review 5.  Environmental factors in causing human cancers: emphasis on tumorigenesis.

Authors:  Umesh T Sankpal; Hima Pius; Moeez Khan; Mohammed I Shukoor; Pius Maliakal; Chris M Lee; Maen Abdelrahim; Sarah F Connelly; Riyaz Basha
Journal:  Tumour Biol       Date:  2012-05-22

Review 6.  Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers.

Authors:  Courtney Schaal; Srikumar P Chellappan
Journal:  Mol Cancer Res       Date:  2014-01-07       Impact factor: 5.852

Review 7.  AKT in cancer: new molecular insights and advances in drug development.

Authors:  Prabhjot S Mundi; Jasgit Sachdev; Carolyn McCourt; Kevin Kalinsky
Journal:  Br J Clin Pharmacol       Date:  2016-06-27       Impact factor: 4.335

8.  High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886).

Authors:  Jieru Meng; Henry Peng; Bingbing Dai; Wei Guo; Li Wang; Lin Ji; John D Minna; Christine M Chresta; Paul D Smith; Bingliang Fang; Jack A Roth
Journal:  Cancer Biol Ther       Date:  2009-11-18       Impact factor: 4.742

9.  Efficacy of polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.

Authors:  Ying Yan; Yian Wang; Qing Tan; Yukihiko Hara; Taik-Koo Yun; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

10.  Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer.

Authors:  Jatinder Kaur; Meenakshi Sawhney; Siddartha Dattagupta; Nootan K Shukla; Anurag Srivastava; Ranju Ralhan
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.